Organon & Co | OGN - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
Glaxosmithkline GBP 3.44B 146M 2026-03
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Merck USD 6.85B 1.52B 2026-06
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
Novartis USD 6.88B 2.68B 2026-03
Organigram Holdings CAD 4.29M 3.28M 2026-03
Organon & Co USD 1.13B 16M 2026-06
Pharma Mar EUR 19.34M 29.53M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 3.85B 727.54M 2026-03